Leap Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Leap Therapeutics's estimated annual revenue is currently $10.4M per year.
- Leap Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Leap Therapeutics has 67 Employees.
- Leap Therapeutics grew their employee count by 49% last year.
Leap Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | President & CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Manufacturing Officer | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | VP, Program Leadership | Reveal Email/Phone |
9 | VP, Biomedical Operations and Head Biometrics | Reveal Email/Phone |
10 | VP, Regulatory Affairs & Quality | Reveal Email/Phone |
Leap Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Leap Therapeutics?
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.
keywords:N/AN/A
Total Funding
67
Number of Employees
$10.4M
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.3M | 67 | 5% | N/A |
#2 | $8.5M | 67 | -12% | $55.9M |
#3 | $5.2M | 67 | -68% | $377.5M |
#4 | $17.5M | 67 | 6% | N/A |
#5 | $9M | 67 | 22% | N/A |